DNL952

DNL952 · Denali Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNL952, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease [Phase 1]

See pricing